MISSISSAUGA, ON, June 23 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND - News) today announced the appointment of Dr. Jason A. Gross as Vice President, Scientific Affairs. In this newly created position, Dr. Gross will be responsible for leading the regulatory, scientific and medical activities of the Company and providing overall strategic direction for its research and development programs.
